Deciphera Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid
Deciphera Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid of $30.63 million as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2024-02-07
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $30.63M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $35.40M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $38.55M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid $40.06M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2023-12-31 | $30.63M 10-K · filed 2024-02-07 |
| 2022-12-31 | $35.40M 10-K · filed 2023-02-07 |
| 2021-12-31 | $38.55M 10-K · filed 2022-02-08 |
| 2020-12-31 | $40.06M 10-K · filed 2021-02-09 |
| 2020-09-30 | $40.68M 10-Q · filed 2020-11-05 |
| 2019-12-31 | $22.83M 10-K · filed 2020-03-09 |
| 2019-09-30 | $541.00K 10-Q · filed 2019-11-04 |